Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease

In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates

(2019) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis

(2019) Nakwon Kwak et al.   EUROPEAN RESPIRATORY JOURNAL

Mycobacterium abscessus and antibiotic resistance: Same as it ever was

(2019) David E Griffith   CLINICAL INFECTIOUS DISEASES

In Vitro and Intracellular Activity of Imipenem Combined with Tedizolid, Rifabutin, and Avibactam against Mycobacterium abscessus

(2019) Eva Le Run et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activities of omadacycline against rapidly growing mycobacteria

(2019) Carolyn Shoen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus

(2019) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

(2018) Jakko van Ingen et al.   EUROPEAN RESPIRATORY JOURNAL

In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense

(2017) Zhijian Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria

(2017) Guilian Li et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Once-daily dosing of amikacin for treatment of Mycobacterium abscessus lung disease

(2017) H. Lee et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus

(2017) Anna Rominski et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan

(2017) Ming-Chun Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

(2017) Charles S Haworth et al.   THORAX

Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates

(2017) Bing Li et al.   Frontiers in Microbiology

Bactericidal and intracellular activity of β-lactams againstMycobacterium abscessus

(2016) Anne-Laure Lefebvre et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Standardized interpretation of antibiotic susceptibility testing and resistance genotyping forMycobacterium abscessuswith regard to subspecies anderm41sequevar

(2016) Faiza Mougari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia

(2015) Kyra Y.L. Chua et al.   PATHOLOGY

Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model

(2014) C.-T. Oh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections

(2014) R. J. Wallace et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

(2013) Wouter Hoefsloot et al.   EUROPEAN RESPIRATORY JOURNAL

Mycobacterium abscessus: a new antibiotic nightmare

(2012) R. Nessar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY